Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -241.83% | 71.53% | 0.00% | -541.98% | 81.16% |
| Total Depreciation and Amortization | -3.03% | 93.56% | 0.00% | -28.07% | -17.81% |
| Total Amortization of Deferred Charges | -- | -- | 0.00% | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -124.68% | 206.65% | 0.00% | -58.98% | 69.00% |
| Cash from Operations | -2,734.34% | 96.15% | 0.00% | -2,346.94% | 105.54% |
| Capital Expenditure | 153.50% | -50.38% | 0.00% | 72.06% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 153.50% | -50.38% | 0.00% | 72.06% | -- |
| Total Debt Issued | 3.86% | 27.39% | 0.00% | -54.20% | 123.98% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -113.82% | 0.00% | 461.90% | -- |
| Cash from Financing | 4.03% | -11.38% | 0.00% | -33.69% | 113.25% |
| Foreign Exchange rate Adjustments | 242.56% | -218.30% | 0.00% | 155.20% | -271.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.85% | 146.26% | 0.00% | -144.51% | 639.60% |